Figure 5.

Sensitivity analyses on the price differential of the bivalent and quadrivalent HPV-vaccines. A positive price difference indicates that the quadrivalent vaccine can be more expensive to be as cost-effective as the bivalent vaccine.

Westra et al. BMC Infectious Diseases 2013 13:75   doi:10.1186/1471-2334-13-75
Download authors' original image